Logo

compact mass spectrometer

Agena Rolls out Seq-It SARS-CoV-2 Variant Panel Globally for Use on MassArray System
Premium

The assay is being positioned as an alternative to next-generation sequencing-based approaches, which its creators view as ponderous and pricey.

Agilent Q3 Revenues Up 6 Percent

The firm's diagnostics and genomics group saw an 11 percent year-over-year revenue increase in the third quarter.

Ascendant Dx Closes on $2M Financing to Develop Proteomic-based Breast Cancer Test

NEW YORK (GenomeWeb) – Proteomics-based diagnostics firm Ascendant Dx today said that it closed on a $2 million funding round, which will support clinical trials for and commercialization of its tears-based breast cancer detection test.

Advion Inks Distribution Deal for Spain, Portugal and South America

NEW YORK (GenomeWeb News) – Advion today said that it has inked a distribution agreement with Konik Group covering Spain, Portugal, and South America, excluding Brazil.

Advion, Agilent Integrate Mass Spec, LC Technologies

NEW YORK (GenomeWeb News) – Advion today said that its expression compact mass spectrometer has been integrated with liquid chromatography systems from Agilent Technologies.
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.